Clinical Trials Logo

Clinical Trial Summary

In this study the impact of two CE marked and FDA approved sternal needles in comparison to intravenous access on the flow-rate of autologous reinfusion of whole blood and the possible hemolysis of red cells post-transfusion in a population of healthy military officers is investigated.


Clinical Trial Description

Intraosseous (IO) access is an old technique for achieving entrance to the systemic circulation, which has gained resurgence in the last 30 years.

Whether due to trauma or disease, vascular collapse may delay or preclude even experienced medical providers from obtaining standard intravenous (IV) access. Access to the vascular system of the critically ill or injured adult or pediatric patient is essential for resuscitation, and flow rates close up to what can be obtained by using intravenous access is preferable in patient needing immediate fluid boluses for shock resuscitation. Intraosseous access takes advantage of the vascularity of cancellous bone, the spongy bone inside the hard, and access to the highly vascular intramedullary space of bones provides a direct link to central circulation. In addition to using long bones, the sternum is used for intraosseous access and has gained increased use especially in combat casualty care.

However, in a recent publication, the intraosseous route used for transfusion of blood components is questioned. Based on theoretical models for flow rates through porous media and personal clinical observations the authors conclude that the maximum flow rates attainable for transfusion of blood via intraosseous route are inadequate for successful resuscitation. They also fear that additional pressure needed to obtain adequate flow rate may cause hemolysis of red blood cells. Further they postulate that as the bone mineral density reaches a peak occurring in the early 20s, and that a small increase in bone density may cause exponential decrease in intrinsic permeability, there could be a 10-fold decrease in permeability in military age causalities compared to the elderly. The critical points highlighted in this review are in great contrast to recent experience with the use of sternal and humeral I.O`s in Operation Enduring Freedom (OEF).

This observational study investigates the impact of two CE marked and FDA approved sternal needles in comparison to intravenous access on the flow-rate of autologous reinfusion of whole blood and the possible hemolysis of red cells post-transfusion in a population of healthy military officers. We also investigate the technical success rate of sternal IO Access between two CE marked and FDA approved sternal Devices. As a supplementary investigation we seek to investigate the anatomic changes as shown by Magnetic Resonance Imaging in individuals who have received multiple intraosseous sternal needles With autologous reinfusion of whole blood. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02924792
Study type Observational
Source Haukeland University Hospital
Contact
Status Completed
Phase N/A
Start date November 2016
Completion date December 5, 2017

See also
  Status Clinical Trial Phase
Completed NCT04149171 - Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage Phase 3
Not yet recruiting NCT06070350 - Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children Phase 3
Not yet recruiting NCT02880163 - REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam N/A
Terminated NCT00750997 - Hypertonic Modulation of Inflammation Following Injury N/A
Terminated NCT03477006 - Pragmatic Prehospital Group O Whole Blood Early Resuscitation Trial Phase 3
Not yet recruiting NCT04987411 - Detection of Exhaled Methane Levels in Hemorrhagic Shock
Recruiting NCT04610814 - Blood Transfusion by Boston MedFlight Registry
Completed NCT02071290 - Effect of Remote Ischemic Conditioning on Trauma Patients With Hemorrhagic Shock N/A
Completed NCT03535441 - HMGB1 Release From Hemorrhagic Shock Patients
Completed NCT03480555 - Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients N/A
Completed NCT03402035 - Shock, Whole Blood, and Assessment of TBI S.W.A.T. (LITES TO 2)
Completed NCT05081063 - Low-Titer O Positive Whole Blood Versus Component Therapy for Emergent Transfusion in Trauma Patients Phase 3
Recruiting NCT03235921 - Use of Nitroglycerine to Improve Signs of Poor Peripheral Perfusion in Patients With Traumatic Hemorrhagic Shock Phase 2
Active, not recruiting NCT03469947 - California Prehospital and In Hospital Antifibrinolytic Therapy Via TXA Phase 3
Completed NCT01411852 - Field Trial of Hypotensive Versus Standard Resuscitation for Hemorrhagic Shock After Trauma Phase 2
Withdrawn NCT01221389 - Study Using Plasma for Patients Requiring Emergency Surgery Phase 4
Recruiting NCT03406598 - Bedside Visual Analysis of Sublingual Microcirculation in Shock Patients
Completed NCT00328133 - The Use of rFVIIa in Trauma Patients: A Multi-Center Case Registry N/A
Completed NCT00379522 - Vasopressin in Traumatic Hemorrhagic Shock Study Phase 2/Phase 3
Completed NCT00945542 - The Trauma- Formula-Driven Versus Lab-Guided Study (TRFL Study) Phase 1/Phase 2